Work

The AppNL-G-F mouse model of Alzheimer’s disease is refractory to regulatory T cell treatment

Year: 2022

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-1443371/v1

Authors: Lidia YSHII, Loriana Mascali, Lubna Kouser, Pierre Lemaitre, Marika Marino, James Dooley, Oliver Burton, Jeason Haughton, Zsuzsanna Callaerts-Vegh, Bart de Strooper, Matthew G Holt, Emanuela Pasciuto, Adrian Liston

Institutions: KU Leuven, Babraham Institute

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Alzheimer's Association, Fonds Wetenschappelijk Onderzoek, Directorate for Biological Sciences, Biotechnology and Biological Sciences Research Council

Awards: G1990583613, G546953014, Develop a mechanistic understanding of how transcriptional and posttranscriptional regulation of gene expression is coordinated by signal transduction pathways., G6160911136, Use of an AAV9-based system for vectored immunoprophylaxis (VIP) targeting SOD1 in amyotrophic lateral sclerosis (ALS)., Immune homeostasis and the immune response, G8677781744

OpenAlex ID: W4226490962

Cites: 26

Cited by: 1

Related to: 10